The Vascular Stent Market is valued at USD 13.6 Bn in 2026.
The Vascular Stent Market is projected to grow at a CAGR of 6% through 2033, reaching USD 19.8 Bn.
The market is driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in drug-eluting and bioresorbable stent technologies.
North America is the dominant regional market for Vascular Stent due to its advanced healthcare infrastructure, high cardiovascular disease burden, and strong adoption of innovative stent technologies.
Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, and Becton, Dickinson, and Company are among the leading players in the Vascular Stent Market.